Learn more about targeted radiopharmaceutical therapy and the mechanism of action of radiotherapeutic agents used for the treatment of tumors expressing specific receptors on their surface.

Somatostatin signaling is an important pathway involved in the pathophysiology of neuroendocrine tumors (NETs) that allows a personalized theranostic approach to their management.